CHLAPEK, Petr, Jakub NERADIL, Martina LOJOVÁ, Karel ZITTERBART, Jaroslav ŠTĚRBA and Renata VESELSKÁ. The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression. Cancer Cell International. 2014, vol. 14, June, p. "nestránkováno", 10 pp. ISSN 1475-2867. Available from: https://dx.doi.org/10.1186/1475-2867-14-51.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression.
Authors CHLAPEK, Petr (203 Czech Republic, belonging to the institution), Jakub NERADIL (203 Czech Republic, belonging to the institution), Martina LOJOVÁ (203 Czech Republic, belonging to the institution), Karel ZITTERBART (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution) and Renata VESELSKÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Cancer Cell International, 2014, 1475-2867.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.766
RIV identification code RIV/00216224:14310/14:00079004
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1186/1475-2867-14-51
UT WoS 000338146500001
Keywords in English all-trans retinoic acid; caffeic acid; celecoxib; medullobastoma; LOX and COX inhibitors
Tags AKR, rivok
Tags International impact, Reviewed
Changed by Changed by: prof. RNDr. Renata Veselská, Ph.D., M.Sc., učo 1260. Changed: 25/11/2015 22:11.
Abstract
A detailed analysis of the expression of 440 cancer-related genes was performed after the combined treatment of medulloblastoma cells with all-trans retinoic acid (ATRA) and inhibitors of lipoxygenases (LOX) and cyclooxygenases (COX). The Daoy and D283 Med medulloblastoma cell lines were chosen for this study. Caffeic acid (an inhibitor of 5-LOX) and celecoxib (an inhibitor on COX-2) were used in combined treatment with ATRA. The results clearly confirmed that the differentiating effects of ATRA should be enhanced via its combined administration with caffeic acid or celecoxib. An increased expression of the genes that encoded the proteins participating in induced differentiation and cytoskeleton remodeling was detected in both cell lines in a concentration-dependent manner. This effect was also observed for the CDKN1A gene encoding the p21 protein, which is an important regulator of the cell cycle, and for the genes encoding proteins that are associated with proteasome activity. Furthermore, our results showed that D283 Med cells are significantly more sensitive to treatment with ATRA alone than Daoy cells.
Links
EE2.3.20.0183, research and development projectName: Centrum experimentální biomedicíny
NR9341, research and development projectName: Modulace antineoplastického efektu retinoidů LOX/COX inhibitory na modelu dětských solidních nádorů: in vitro studie
Investor: Ministry of Health of the CR
PrintDisplayed: 26/4/2024 18:10